More importantly, apart from functioning as a part of the RAD9A-HUS1-RAD1 complex, RAD9A independently drives prostate cancer metastasis by controlling AGR2 abundance (Broustas et al., 2019). Here, RAD9A is linked to prostate carcinoma.